Oppenheimer & Co. Inc. raised its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 2.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 55,815 shares of the company’s stock after buying an additional 1,175 shares during the period. Oppenheimer & Co. Inc.’s holdings in Colgate-Palmolive were worth $4,086,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of CL. Chickasaw Capital Management LLC raised its position in Colgate-Palmolive by 218.3% in the first quarter. Chickasaw Capital Management LLC now owns 16,920 shares of the company’s stock worth $1,238,000 after buying an additional 11,605 shares during the last quarter. Meritage Portfolio Management raised its position in Colgate-Palmolive by 0.3% in the first quarter. Meritage Portfolio Management now owns 95,879 shares of the company’s stock worth $7,017,000 after buying an additional 255 shares during the last quarter. Eastern Bank raised its position in Colgate-Palmolive by 0.8% in the first quarter. Eastern Bank now owns 10,939 shares of the company’s stock worth $801,000 after buying an additional 89 shares during the last quarter. ProShare Advisors LLC raised its position in Colgate-Palmolive by 9.9% in the first quarter. ProShare Advisors LLC now owns 879,652 shares of the company’s stock worth $64,382,000 after buying an additional 79,323 shares during the last quarter. Finally, Lynch & Associates IN raised its position in Colgate-Palmolive by 4.1% in the first quarter. Lynch & Associates IN now owns 29,542 shares of the company’s stock worth $2,162,000 after buying an additional 1,175 shares during the last quarter. 73.85% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Company (CL) traded down 0.41% during mid-day trading on Friday, hitting $71.26. 2,023,502 shares of the company were exchanged. The company has a 50 day moving average of $72.84 and a 200 day moving average of $72.74. Colgate-Palmolive Company has a 12-month low of $63.43 and a 12-month high of $77.27. The stock has a market cap of $62.77 billion, a P/E ratio of 26.48 and a beta of 0.80.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.72. The business had revenue of $3.83 billion for the quarter, compared to the consensus estimate of $3.89 billion. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. Colgate-Palmolive’s revenue for the quarter was down .5% on a year-over-year basis. During the same period last year, the company posted $0.70 EPS. On average, equities research analysts expect that Colgate-Palmolive Company will post $2.89 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, August 15th. Investors of record on Tuesday, July 18th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, July 14th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.25%. Colgate-Palmolive’s dividend payout ratio is 59.48%.

TRADEMARK VIOLATION WARNING: This piece of content was first posted by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another website, it was illegally stolen and reposted in violation of United States & international copyright law. The correct version of this piece of content can be read at https://www.dailypolitical.com/2017/08/12/oppenheimer-co-inc-raises-position-in-colgate-palmolive-company-cl.html.

CL has been the subject of a number of analyst reports. Jefferies Group LLC initiated coverage on shares of Colgate-Palmolive in a research note on Tuesday, April 18th. They set a “hold” rating and a $78.00 target price for the company. Royal Bank Of Canada reissued a “hold” rating and set a $74.00 target price on shares of Colgate-Palmolive in a research note on Monday, April 24th. UBS AG reissued a “neutral” rating and set a $78.00 target price (down from $79.00) on shares of Colgate-Palmolive in a research note on Tuesday, May 2nd. Zacks Investment Research lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Wednesday, May 3rd. Finally, Vetr lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 target price for the company. in a research note on Wednesday, May 17th. Two investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have given a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $75.82.

In related news, COO Justin Skala sold 74,374 shares of the stock in a transaction that occurred on Thursday, July 27th. The shares were sold at an average price of $72.51, for a total value of $5,392,858.74. Following the sale, the chief operating officer now directly owns 97,177 shares in the company, valued at approximately $7,046,304.27. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Dennis J. Hickey sold 73,872 shares of the stock in a transaction that occurred on Thursday, August 3rd. The shares were sold at an average price of $71.80, for a total transaction of $5,304,009.60. Following the completion of the sale, the chief financial officer now owns 484,985 shares in the company, valued at $34,821,923. The disclosure for this sale can be found here. Insiders sold a total of 203,969 shares of company stock worth $14,711,068 over the last quarter. 1.02% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.